Lori R. Harrelson serves as Executive at ARGOS THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Lori R. Harrelson has executed 8 insider transactions totaling $30.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 25, 2018 involved selling 22,629 shares valued at $0.
Lori R. Harrelson currently holds 11,776 shares of ARGOS THERAPEUTICS INC (ARGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lori R. Harrelson has been a net seller of ARGS stock. They have purchased $0 and sold $30.0K worth of shares.
Lori R. Harrelson's most recent insider trade was on Apr 25, 2018, when they sold 22,629 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 10, 2018 | ARGS | $10.3K | Sale | 64,329 | $0.16 | Discretionary |
| Jan 9, 2018 | ARGS | $10.3K | Sale | 64,329 | $0.16 | Discretionary |
| Jan 3, 2018 | ARGS | $9.5K | Sale | 59,072 | $0.16 | Discretionary |
| Aug 30, 2017 | ARGS | $0 | Award | 320,683 | $N/A | Discretionary |
| Jan 20, 2017 | ARGS | $0 | Award | 3,694 | $N/A | Discretionary |
| Jan 8, 2016 | ARGS | $0 | Award | 28,125 | $N/A | Discretionary |